---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-008825"
form_type: "8-K"
ticker: "AZTA"
cik: "0000933974"
company_name: "Azenta, Inc."
filed_at: "2023-05-09T23:59:59+00:00"
generated_at: "2026-06-15T11:38:28.713181+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Azenta Q2 FY23 revenue $148M, GAAP EPS loss $0.03, guided Q3 below consensus

## Summary
- Revenue $148M (+2% YoY; -17% sequentially); non-GAAP diluted EPS ($0.06) vs $0.12 a year ago.
- Life Sciences Products revenue $59M (+10% YoY) but B Medical $15M, below expectations due to order delays.
- Adjusted EBITDA ($2.4M) vs $19M prior year; expects $15M annual cost savings from realignment.
- Realigns into three groups (Multi-Omics, Sample Management, B Medical) effective Oct 1, 2023.
- Q3 FY23 guidance: revenue $150-168M; non-GAAP EPS ($0.07)-$0.03; GAAP EPS ($0.29)-($0.19).

## SEC filing metadata
- accession: 0001558370-23-008825
- form_type: 8-K
- ticker: AZTA
- cik: 0000933974
- company_name: Azenta, Inc.
- filed_at: 2023-05-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/933974/000155837023008825/0001558370-23-008825-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/933974/000155837023008825/azta-20230509x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-008825
- JSON: https://secwatch.observer/filing/0001558370-23-008825.json
- Plain text: https://secwatch.observer/filing/0001558370-23-008825.txt

## Key facts
- Earnings Releases
  Azenta, Inc. reported financial results for the second quarter ended March 31, 2023.
  - Period: the second quarter ended March 31, 2023
  - Result: reported results
  source text: On May 9, 2023, Azenta, Inc. (“Azenta” or the “Company”) announced via press release its financial results for the fiscal quarter ended March 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/933974/000155837023008825/0001558370-23-008825-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.